6.72

1.97% 0.13

Personalis Inc (PSNL)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$6.59

Offen:

$6.66

24-Stunden-Volumen:

1.99M

Relative Volume:

1.39

Marktkapitalisierung:

$703.13M

Einnahmen:

$73.48M

Nettoeinkommen (Verlust:

$-108.30M

KGV:

-2.9867

EPS:

-2.25

Netto-Cashflow:

$-67.17M

1W Leistung:

-14.29%

1M Leistung:

-18.15%

6M Leistung:

+14.87%

1J Leistung:

+88.24%

1-Tages-Spanne:

$6.6505

$7.105

1-Wochen-Bereich:

$6.56

$8.4156

52-Wochen-Spanne:

$2.8262

$11.50

Personalis Inc Stock (PSNL) Company Profile

Firmenname

Personalis Inc

Sektor

Healthcare (1116)

Branche

Diagnostics & Research (52)

Telefon

650-752-1300

Adresse

6600 DUMBARTON CIRCLE, FREMONT, CA

Mitarbeiter

260

Twitter

@PersonalisInc

Nächster Verdiensttermin

2024-11-06

Neueste SEC-Einreichungen

PSNL's Discussions on Twitter

Compare PSNL vs TMO, DHR, IDXX, A, WAT

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
PSNL Personalis Inc	6.72	703.13M	73.48M	-108.30M	-67.17M	-2.25
TMO Thermo Fisher Scientific Inc	464.37	172.51B	44.56B	6.72B	6.29B	17.74
DHR Danaher Corp	187.32	132.46B	24.57B	3.60B	5.26B	5.051
IDXX Idexx Laboratories Inc	573.82	45.69B	4.30B	1.06B	1.04B	13.08
A Agilent Technologies Inc	111.51	31.51B	7.07B	1.29B	993.00M	4.5355
WAT Waters Corp	286.57	28.11B	3.17B	642.63M	516.49M	10.77

Personalis Inc Stock (PSNL) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-12-02	Fortgesetzt	Morgan Stanley	Equal-Weight
2025-05-15	Eingeleitet	Guggenheim	Buy
2025-03-17	Eingeleitet	Craig Hallum	Buy
2023-02-06	Hochstufung	Needham	Hold → Buy
2022-01-07	Hochstufung	BofA Securities	Neutral → Buy
2021-11-05	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2021-11-03	Herabstufung	Needham	Buy → Hold
2021-10-15	Fortgesetzt	Cowen	Outperform
2021-09-20	Bestätigt	Needham	Buy
2021-05-06	Hochstufung	Oppenheimer	Perform → Outperform
2021-01-28	Eingeleitet	Truist	Buy
2021-01-04	Herabstufung	BofA Securities	Buy → Neutral
2020-11-12	Bestätigt	Needham	Buy
2020-11-06	Herabstufung	Oppenheimer	Outperform → Perform
2020-10-19	Eingeleitet	Citigroup	Buy
2020-10-08	Eingeleitet	BTIG Research	Buy
2020-08-27	Eingeleitet	H.C. Wainwright	Buy
2020-08-18	Eingeleitet	Needham	Buy
2019-09-26	Hochstufung	BofA/Merrill	Neutral → Buy
2019-07-15	Eingeleitet	BofA/Merrill	Neutral
2019-07-15	Eingeleitet	Cowen	Outperform
2019-07-15	Eingeleitet	Morgan Stanley	Overweight
2019-07-15	Eingeleitet	Oppenheimer	Outperform

Alle ansehen

Personalis Inc Aktie (PSNL) Neueste Nachrichten

Mar 12, 2026

Personalis Announces New Publication Advancing Neoadjuvant Treatment Monitoring in Breast Cancer with NeXT Personal - BioSpace

Mar 12, 2026

Personalis (PSNL) Publishes Promising Study on Cancer Detection Method - GuruFocus

Mar 12, 2026

Personalis Announces New Publication Advancing Neoadjuvant Treatment Monitoring in Breast Cancer with NeXT Personal® - Business Wire

Mar 12, 2026

Mar 11, 2026

Personalis, Inc. (NASDAQ:PSNL) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Mar 11, 2026

Mar 10, 2026

Growth Report: Is Personalis Inc showing insider buyingEarnings Growth Report & Consistent Profit Trade Alerts - baoquankhu1.vn

Mar 10, 2026

Mar 08, 2026

Personalis (NASDAQ:PSNL) Rating Increased to Hold at Wall Street Zen - MarketBeat

Mar 08, 2026

Mar 06, 2026

Momentum Shift: Is Personalis Inc benefiting from interest rate changesJuly 2025 Earnings & Short-Term Trading Opportunity Alerts - baoquankhu1.vn

Mar 06, 2026

Is Personalis Inc. stock attractive after correctionTrade Risk Summary & Weekly High Momentum Picks - Naître et grandir

Mar 06, 2026

Personalis Stock Pre-Market (-5.3%): FY26 Guidance Overshadows Q4 EPS Beat - Trefis

Mar 06, 2026

Mar 05, 2026

Morgan Stanley Has Lowered Expectations for Personalis (NASDAQ:PSNL) Stock Price - MarketBeat

Mar 05, 2026

PSNL: Morgan Stanley Maintains Equal-Weight, Lowers Price Target - GuruFocus

Mar 05, 2026